Force Therapeutics, a New York-based provider of episode-based digital care delivery, today announced it has raised $21 million funding led by Insight Venture Partners. The funding will fuel Force's rapid product innovation, national expansion across major health systems, and client growth. Force is currently deployed in 60 facilities around the country and powers digital care management at leading health systems, including Geisinger, NYU Langone, Northwell Health, University Hospitals of
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
1DROP Raises $4.25M to Support Commercialization of Portable Medical Diagnostics Platform
1DROP, a life sciences startup developing and commercializing an easy to use laboratory quality, portable medical diagnostic testing platform has raised $4.25 million in Series A funding led by led by Christian Wildmoser (former partner CVC Capital Partners & Swiss Startup Group Investor). The round also included participation from private investors of the Swiss Startup Group including Dr. Hans-Peter Strebel (owner of On Your Marks), Beat Schillig (IFJ Institute for Young Entrepreneurs) and
Read More
WellSpan Health, Sweetch Partner to Deploy AI-Driven App for Diabetes Prevention
WellSpan Health partners with Sweetch to deploy its AI-based app to deliver large-scale prediction and prevention of diabetes to augment its employee wellness program.Diabetes is an epidemic, and our health systems are paying the price. With one in 11 adults affected globally and costs for people suffering from diabetes over 2x higher than those without the disease, it’s a pressing issue – and the latest technologies can help alleviate it.Today, integrated healthcare system WellSpan Health
Read More
Modis Therapeutics Raises $30M for Developing Medicines for Patients with Rare Genetic Diseases
Modis Therapeutics, Inc., a company developing medicines for patients with rare genetic diseases has raised $30 million in Series A funding led by F-Prime Capital Partners and OrbiMed. Joshua Grass, former F-Prime Entrepreneur-in-Residence and head of Corporate Development at BioMarin Pharmaceutical, has joined as President and Chief Executive Officer. Founding investor Aceras Life Sciences, LLC and new investor Osage University Partners also participated in the financing.Founded in 2016, Modis
Read More
Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database
uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 million in Series C funding. The round was led by OS Fund, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. Now, uBiome is mining its database (the world's largest human microbiome database) to discover new therapeutic targets, with an initial focus on
Read More
Click Therapeutics Lands $17M to Advance Prescription Digital Therapeutics Platform
Click Therapeutics, Inc. (“Click”), a provider of Digital Therapeutics solutions as prescription medical treatments, has raised $17 million in funding led by Sanofi Ventures, the corporate venture capital arm of Sanofi. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Among these areas are rare diseases, vaccines, potential cures in other core areas of Sanofi’s
Read More
Propeller Health Lands $20M to Develop Digital Medicine Platform Across Therapeutic Areas
Propeller Health, a digital therapeutics company, toay announced a $20 million funding round led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One. Propeller plans to use the proceeds from the funding to support Propeller's investment in its pipeline of digital therapeutics and additional connected devices for the treatment of chronic respiratory disease, an area of continued market growth for the company. Propeller
Read More
Report: Patients Worried Digital Therapeutics will Expose Them to Unwanted Surveillance
New research released today by healthcare innovation consultancy Enspektos, LLC reveals that digital therapeutics, defined as innovations such as prescription medications with embedded sensors and mobile applications that may one day replace drugs, are rapidly growing in scope and importance globally.The research also highlights deep patient concerns about whether digital therapeutics will expose them to unwanted surveillance or that data collected by these applications could be sold or used
Read More
WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Through Samsung Health
Samsung Electronics America, Inc. and WellDoc, a digital therapeutic company, announced today that Samsung Health users now have access to a new consumer version of WellDoc’s digital platform known as the Diabetes Wellness Program (DWP). Samsung Health users now have access to a new Diabetes Wellness Program (DWP) available through the Samsung Health service that is powered by WellDoc’s platform used in its BlueStar® product. It is available to individuals in the United States with Samsung
Read More
Why Did the Global Digital Health Market Strengthen During Q4 2017?
Healthcare innovation consultancy Enspektos, LLC, today released the latest edition of its quarterly study, digihealth impact trac. The report focuses on key Q4 2017 market themes and previews five digital health trends that will matter in 2018. The research reveals that telemedicine is having a far-reaching impact as adoption surges globally. Most importantly, telemedicine solutions are delivering economic benefits and re-shaping the patient-physician relationship, as clinicians learn what it
Read More